3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Interventions
Nivolumab
7
cabozantinib
5
Specimen Handling
5
Ipilimumab
5
CTLA-4 Antigen
4
Magnetic Resonance Spectroscopy
2
sodium-iodide symporter
1
sitravatinib
1
lenvatinib
1
fludarabine
1
Zoledronic Acid
1
Tissue Banks
1
Radiotherapy
1
Radiopharmaceuticals
1
Pluvicto
1
Ibandronic Acid
1
Everolimus
1
Diphosphonates
1
Denosumab
1
Blood Specimen Collection
1
Biopsy
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Clear-cell metastatic renal cell carcinoma
×
Radiopharmaceuticals
×
90 days
×
Clear all
NCT06059014
2026-04-24
PRadR
Centre Leon Berard
Phase 1/2
Completed
6 enrolled